CoChat

Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells

Open access
Dai, Xiao-Yang, Zhuang, Lin-Han, Wang, Dan-Dan, Zhou, Tian-Yi, Chang, Lin-Lin, Gai, Ren-Hua, Zhu, Di-Feng, Yang, Bo, Zhu, Hong, He, Qiao-Jun · 2016 · Oncotarget
Cited by 72

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

// Xiao-Yang Dai 1, 2, * , Lin-Han Zhuang 1, * , Dan-Dan Wang 1, * , Tian-Yi Zhou 1 , Lin-Lin Chang 1 , Ren-Hua Gai 2 , Di-Feng Zhu 2 , Bo Yang 1 , Hong Zhu 1 , Qiao-Jun He 1 1 Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China 2 Center for Drug Safety Evaluation and Research of Zhejiang University, Hangzhou 310058, China * These authors contributed equally to this work Correspondence to: Hong Zhu, e-mail: hongzhu@zju.edu.cn Qiao-Jun He, e-mail: qiaojunhe@zju.edu.cn Keywords: hepatocellular carcinoma, SN38, hypoxia, resistance, yes-associated protein (YAP) Received: June 23, 2015 Accepted: December 29, 2015 Published: January 12, 2016 ABSTRACT Although hypoxia is a prominent feature contributing to the therapeutic resistance of hepatocellular carcinoma cells (HCC) against chemotherapeutic agents, including the Topoisomerase I inhibitor SN38, the underlying mechanism is not fully understood and its understanding remains a major clinical challenge. In the present study, we found that hypoxia-induced nuclear translocation and accumulation of YAP acted as a survival input to promote resistance to SN38 in HCC. The induction of YAP by hypoxia was not mediated by HIF-1α because manipulating the abundance of HIF-1α with CoCl2, exogenous expression, and RNA interference had no effect on the phosphorylation or total levels of YAP. The mevalonate-HMG-CoA reductase (HMGCR) pathway may modulate the YAP activation under hypoxia. Combined YAP inhibition using either siRNA or the HMGCR inhibitor statins together with SN38 treatment produced improved anti-cancer effects in HCC cells. The increased anti-cancer effect of the combined treatment with statins and irinotecan (the prodrug of SN-38) was further validated in a human HepG2 xenograft model of HCC in nude mice. Taken together, our findings identify YAP as a novel mediator of hypoxic-resistance to SN38. These results suggest that the administration of SN28 together with the suppression of YAP using statins is a promising strategy for enhancing the treatment response in HCC patients, particularly in advanced stage HCC cases presenting hypoxic resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6903

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

Metadata

Authors
Dai, X.-Y., Zhuang, L.-H., Wang, D.-D., Zhou, T.-Y., Chang, L.-L., Gai, R.-H., Zhu, D.-F., Yang, B., Zhu, H., & He, Q.-J.
Venue
Oncotarget
Published
2016-01-12
Volume
7
Issue
6
Pages
6933-6947
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2299368506
Cited by
72
References
17
FWCI
6.84
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.